N-[5-(2H-1,3-Benzodioxol-5-Yl)-6-{2-[(5-Bromopyrimidin-2-Yl)Oxy]Ethoxy}Pyrimidin-4-Yl]-N'-(2-Methoxyethyl)Sulfuric Diamide

1 trials

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

0 Completed trials

1 Sponsors

3 Countries

Phase II

Phase II: 1

Sponsors using this IMP

University Medical Center Groningen 1

All trials

1 total

ASPIRE-1: dApagliflozin SC0062 and Prevention of renal Injury; a Randomized Evaluation Not authorised

2023-504404-28-00 Phase II 3 countries University Medical Center Groningen

Showing 1–1 of 1 trials

← All drugs A–Z